Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

462.10 +2.18 (+0.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,115,378
Open 458.06
Bid (Size) 458.60 (1)
Ask (Size) 467.00 (2)
Prev. Close 459.92
Today's Range 456.86 - 465.90
52wk Range 348.46 - 519.88
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 No-Brainer Growth Stocks to Buy in December
Via The Motley Fool
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
Via The Motley Fool

Performance

YTD
+12.46%
+12.46%
1 Month
-8.03%
-8.03%
3 Month
-1.91%
-1.91%
6 Month
-4.38%
-4.38%
1 Year
+31.97%
+31.97%

More News

Read More
FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
It’s Been A Tough Month For Healthcare Stocks
Via Talk Markets
Topics ETFs Stocks / Equities
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
Got $500? 1 Biotech Stock to Buy and Hold Forever
Via The Motley Fool
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
Via Benzinga
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
Via The Motley Fool
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?
Via The Motley Fool
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Via The Motley Fool
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
Via The Motley Fool
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity
Via The Motley Fool
Biotech Stocks Are Rallying: What Is Your Playbook?
Via Talk Markets
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
Via Benzinga
Assessing Vertex Pharmaceuticals: Insights From 11 Financial Analysts
Via Benzinga
Five S&P 500 Stocks, All Elite IBD Giants, Near Buy Points
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
2 Biotech Stocks You Can Buy Hand Over Fist This Month
Via The Motley Fool
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
Via Benzinga
5 Top Stocks to Buy in November
Via The Motley Fool
My 2 Favorite Growth Stocks to Buy Hand Over Fist in November
Via The Motley Fool
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Vertex Pharmaceuticals Beats Third-Quarter Estimates As Pain Treatment Looms
Via Investor's Business Daily
Vertex Reports Third Quarter 2024 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.